Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: A review

被引:38
作者
Antonio Moreno, Juan [1 ]
Yuste, Claudia [2 ]
Gutierrez, Eduardo [3 ]
Sevillano, Angel M. [3 ]
Rubio-Navarro, Alfonso [1 ]
Manuel Amaro-Villalobos, Juan [1 ]
Praga, Manuel [3 ]
Egido, Jesus [1 ,4 ]
机构
[1] Univ Autonoma Madrid, Renal Vasc & Diabet Res Lab, IIS Fdn Jimenez Diaz, Ave Reyes Catol 2, Madrid 28040, Spain
[2] Gregorio Maranon Hosp, Dept Nephrol, Madrid 28007, Spain
[3] Hosp 12 Octubre, Dept Nephrol, E-28041 Madrid, Spain
[4] Spanish Biomed Res Network Diabet & Associated Me, Madrid, Spain
关键词
Haematuria; Chronic kidney disease; Acute kidney injury; Red blood cells; Glomerulonephritis; ACUTE-RENAL-FAILURE; STEROID PULSE THERAPY; LONG-TERM PROGNOSIS; RED-CELL TRAVERSE; IGA NEPHROPATHY; NATURAL-HISTORY; ALPORT-SYNDROME; MACROSCOPIC HEMATURIA; MICROSCOPIC HEMATURIA; CLINICAL REMISSION;
D O I
10.1007/s00467-015-3119-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Haematuria has long been considered to be a benign condition associated with glomerular diseases. However, new evidences suggest that haematuria has a pathogenic role in promoting kidney disease progression. An increased risk for end-stage renal disease has been reported in adolescents and young adults with persistent microscopic haematuria. A persistent impairment of renal function has been also reported following macroscopic haematuria-associated acute kidney injury in immunoglobulin A nephropathy. Haematuria-induced renal damage has been related to oxidant, cytotoxic and inflammatory effects induced by haemoglobin or haem released from red blood cells. The pathophysiological origin of haematuria may be due to a more fragile and easily ruptured glomerular filtration barrier, as reported in several glomerular diseases. In this review we describe a number of the key issues associated with the epidemiology and pathogenesis of haematuria-associated diseases, provide an update of recent knowledge on the role of haematuria on renal function outcome and discuss specific therapeutic approaches in this setting.
引用
收藏
页码:523 / 533
页数:11
相关论文
共 101 条
[31]   Renal manifestations of patients with MYH9-related disorders [J].
Han, Kyoung Hee ;
Lee, HyunKyung ;
Kang, Hee Gyung ;
Moon, Kyung Chul ;
Lee, Joo Hoon ;
Park, Young Seo ;
Ha, Il Soo ;
Ahn, Hyo Seop ;
Choi, Yong ;
Cheong, Hae Il .
PEDIATRIC NEPHROLOGY, 2011, 26 (04) :549-555
[32]   Renal survival in pediatric patients with IgA nephropathy [J].
Hastings, M. Colleen ;
Delos Santos, Noel M. ;
Wyatt, Robert J. .
PEDIATRIC NEPHROLOGY, 2007, 22 (02) :317-318
[33]  
HEYMAN SN, 1995, NEPHROL DIAL TRANSPL, V10, P591
[34]  
HIATT RA, 1994, CANCER EPIDEM BIOMAR, V3, P439
[35]   The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy [J].
Hirano, Keita ;
Kawamura, Tetsuya ;
Tsuboi, Nobuo ;
Okonogi, Hideo ;
Miyazaki, Yoichi ;
Ikeda, Masato ;
Matsushima, Masato ;
Hanaoka, Kazushige ;
Ogura, Makoto ;
Utsunomiya, Yasunori ;
Hosoya, Tatsuo .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (04) :555-562
[36]   Alport's syndrome, Goodpasture's syndrome, and type IV collagen [J].
Hudson, BG ;
Tryggvason, K ;
Sundaramoorthy, M ;
Neilson, EG .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25) :2543-2556
[37]   Renal biopsies in children: current practice and audit of outcomes [J].
Hussain, Farida ;
Mallik, Meeta ;
Marks, Stephen D. ;
Watson, Alan R. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (02) :485-489
[38]   Proteinuria and the risk of developing end-stage renal disease [J].
Iseki, K ;
Ikemiya, Y ;
Iseki, C ;
Takishita, S .
KIDNEY INTERNATIONAL, 2003, 63 (04) :1468-1474
[39]   Risk of developing end-stage renal disease in a cohort of mass screening [J].
Iseki, K ;
Iseki, C ;
Ikemiya, Y ;
Fukiyama, K .
KIDNEY INTERNATIONAL, 1996, 49 (03) :800-805
[40]  
Jais JP, 2000, J AM SOC NEPHROL, V11, P649, DOI 10.1681/ASN.V114649